| Morris Speech Therapy Associates, Limited Liability Company | |
|
8 Humphrey Rd, Morristown, NJ 07960-5708 | |
| (201) 787-6786 | |
| Not Available |
| Full Name | Morris Speech Therapy Associates, Limited Liability Company |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 8 Humphrey Rd, Morristown, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407295603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00582700 (New Jersey) | Primary |
| Provider Name | Michele Demarest |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1780810861 PECOS PAC ID: 9032353768 Enrollment ID: I20131021001621 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Caroline A Sinico |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1811412364 PECOS PAC ID: 3375970577 Enrollment ID: I20200228000790 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Alexis Passarelli |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1598903791 PECOS PAC ID: 6608291711 Enrollment ID: I20200806002390 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Lisa R Wolkoff |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1669919395 PECOS PAC ID: 5496165391 Enrollment ID: I20201104001617 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Alison Michelle Hinman |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1417588930 PECOS PAC ID: 3072921394 Enrollment ID: I20210426000973 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Stacy Jouaux |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1235541210 PECOS PAC ID: 1153714886 Enrollment ID: I20220202000213 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Alison R Del Duca |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1750885869 PECOS PAC ID: 3476948233 Enrollment ID: I20220315001658 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Lynn Remington |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1548902695 PECOS PAC ID: 3375924087 Enrollment ID: I20220712004031 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Alexa Chirichella |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1861122509 PECOS PAC ID: 3971984253 Enrollment ID: I20220718002426 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Sophia Blaney |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1821742990 PECOS PAC ID: 1658755418 Enrollment ID: I20220829002951 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Maria I Samara |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1134869373 PECOS PAC ID: 9436533080 Enrollment ID: I20220830003985 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Sarah Glasspool |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1356763361 PECOS PAC ID: 3274903976 Enrollment ID: I20221221000090 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Daniela Talledo |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1861112955 PECOS PAC ID: 4486024841 Enrollment ID: I20221228002686 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Ashana Torani |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1164130076 PECOS PAC ID: 1254701626 Enrollment ID: I20221228003005 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Melissa Gilmour |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1023711835 PECOS PAC ID: 1254797590 Enrollment ID: I20230511003049 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Sara Tirpak |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1992832042 PECOS PAC ID: 9931566007 Enrollment ID: I20230605002345 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Adriana Hemans |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1689243529 PECOS PAC ID: 0547624462 Enrollment ID: I20230912000371 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Provider Name | Kelly J Pezzanite |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1639309230 PECOS PAC ID: 7911361514 Enrollment ID: I20230915000458 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Morris Speech Therapy Associates, Limited Liability Company 8 Humphrey Rd, Morristown, NJ 07960-5708 Ph: (201) 787-6786 | Morris Speech Therapy Associates, Limited Liability Company 8 Humphrey Rd, Morristown, NJ 07960-5708 Ph: (201) 787-6786 |
News Archive
The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Injuries to nerve fibers in the brain, spinal cord, and optic nerves usually result in functional losses as the nerve fibers are unable to regenerate.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
› Verified 6 days ago
Melissa Gilmour, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 55 Madison Ave Ste 400, Morristown, NJ 07960 Phone: 201-787-6786 | |
Mrs. Stacey H Simon, MA CCC -SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Park Ave, Morristown, NJ 07960 Phone: 973-292-6555 | |
Kelly Zecca, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 57 Woodland Ave, Morristown, NJ 07960 Phone: 973-722-4808 | |
Jennifer Vill, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 320 South St Apt 16d, Morristown, NJ 07960 Phone: 732-690-7146 | |
Lisa Demasi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 973-971-4451 | |
Bonnie Susser, M.A. CCC(SP) Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26 Madison Ave, Morristown, NJ 07960 Phone: 973-292-2265 | |
Ms. Catherine Gaestel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Lindsley Dr Ste 207, Morristown, NJ 07960 Phone: 973-971-0770 |